Drug Markets/Methotrexate

Methotrexate

38 NDCs across 16 manufacturers|23 Generic,15 Brand

Methotrexate is used to treat juvenile arthritis, rheumatoid arthritis, breast neoplasms, choriocarcinoma, crohn disease and esophageal neoplasms, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Oct 11, 2013. In 2024, Medicare Part D spent $246K on Methotrexate across 238 claims for 84 beneficiaries.

Methotrexate is available as 38 NDCs from 16 manufacturers (23 generic, 15 brand), with NADAC prices from $0.65 to $960.29 per MLthe most expensive product costs about 1,489× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Active FDA drug shortage

14 Methotrexate presentations are currently listed in FDA's drug shortage database (first posted Mar 13, 2023). Shortages can move NADAC prices in the following weeks.

Total NDCs

38

23G / 15B

Manufacturers

16

competing in market

Price Spread

$0.65 – $960.29

per ML, 24 of 38 NDCs

7d Activity

21719 flat

avg -1.1% WoW · of 38 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

38 NDCs total, 38 shown

Drug Price 7d Change
RASUVO 7.5 MG/0.15 ML AUTOINJ
$960.2932
per ML
RASUVO 10 MG/0.2 ML AUTOINJ
$721.8144
per ML
RASUVO 12.5 MG/0.25 ML AUTOINJ
$574.8679
per ML
OTREXUP 15 MG/0.4 ML AUTO-INJ
$484.2097
per ML
OTREXUP 20 MG/0.4 ML AUTO-INJ
$480.8553
per ML
RASUVO 15 MG/0.3 ML AUTOINJ
$478.2833
per ML
OTREXUP 17.5 MG/0.4 ML AUTOINJ
$476.9597
per ML
OTREXUP 25 MG/0.4 ML AUTO-INJ
$475.8075
per ML
RASUVO 17.5 MG/0.35 ML AUTOINJ
$409.9292
per ML
RASUVO 20 MG/0.4 ML AUTOINJ
$362.4800
per ML
RASUVO 25 MG/0.5 ML AUTOINJ
$287.8292
per ML
TREXALL 10 MG TABLET
$48.1352
per EA
-0.11%
TREXALL 7.5 MG TABLET
$36.2091
per EA
TREXALL 5 MG TABLET
$24.0884
per EA
XATMEP 2.5 MG/ML ORAL SOLUTION
$21.7635
per ML
METHOTREXATE 50 MG/2 ML VIAL
$3.1283
per ML
-3.66%
METHOTREXATE 50 MG/2 ML VIAL
$3.1283
per ML
-3.66%
METHOTREXATE 50 MG/2 ML VIAL
$3.1283
per ML
-3.66%
METHOTREXATE 50 MG/2 ML VIAL
$1.7563
per ML
+2.02%
METHOTREXATE 50 MG/2 ML VIAL
$1.7563
per ML
+2.02%
METHOTREXATE 50 MG/2 ML VIAL
$1.2379
per ML
-0.81%
METHOTREXATE 250 MG/10 ML VIAL
$0.8029
per ML
METHOTREXATE 250 MG/10 ML VIAL
$0.7020
per ML
-1.69%
METHOTREXATE 1 GRAM/40 ML VIAL
$0.6450
per ML
METHOTREXATE 1 GRAM/40 ML VIAL
$0.6450
per ML
METHOTREXATE 1 GRAM/40 ML VIAL
$0.6450
per ML
METHOTREXATE 1 GRAM/40 ML VIAL
$0.6450
per ML
METHOTREXATE 2.5 MG TABLET
$0.1566
per EA
-1.12%
METHOTREXATE 2.5 MG TABLET
$0.1566
per EA
-1.12%
METHOTREXATE 2.5 MG TABLET
$0.1566
per EA
-1.12%
METHOTREXATE 2.5 MG TABLET
$0.1566
per EA
-1.12%
METHOTREXATE 2.5 MG TABLET
$0.1566
per EA
-1.12%
METHOTREXATE 2.5 MG TABLET
$0.1566
per EA
-1.12%
METHOTREXATE 2.5 MG TABLET
$0.1566
per EA
-1.12%
METHOTREXATE 2.5 MG TABLET
$0.1566
per EA
-1.12%
METHOTREXATE 2.5 MG TABLET
$0.1566
per EA
-1.12%
METHOTREXATE 2.5 MG TABLET
$0.1566
per EA
-1.12%
METHOTREXATE 2.5 MG TABLET
$0.1566
per EA
-1.12%

Frequently Asked Questions

What is Methotrexate used to treat?

Methotrexate is used to treat juvenile arthritis, rheumatoid arthritis, breast neoplasms, choriocarcinoma, crohn disease and esophageal neoplasms, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Methotrexate?

In 2024, Medicare Part D spent $246K on Methotrexate across 238 claims for 84 beneficiaries.

Is Methotrexate in shortage?

Yes — FDA's drug shortage database currently lists 14 Methotrexate presentations with status "Current", first posted Mar 13, 2023.

How many Methotrexate products are on the market?

The Methotrexate drug market contains 38 NDCs from 16 manufacturers — 23 generic and 15 brand products.

What is the price range for Methotrexate?

NADAC reference prices for Methotrexate range from $0.6450 to $960.2932 per ML — the most expensive product costs about 1,489× the cheapest. 14 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.

Is generic Methotrexate cheaper than brand?

The average generic NADAC for Methotrexate is $1.5184 per ML, versus $477.9244 for brand-labeled products — brand versions average about 315× the generic price.

Which manufacturers make Methotrexate?

16 manufacturers list Methotrexate in NADAC. Ranked by number of NDCs, the largest are Medexus Pharma Inc. (7), Hospira Inc. (5), Antares Pharma, Inc. (4), Accord Healthcare Inc. (4), Teva Women's Health, Inc. (3).

How has the price of Methotrexate changed recently?

Over the past 7 days, 2 Methotrexate NDCs rose and 17 fell, with a market-wide average change of -1.1%.